The glycosylation effects on inflammation are critical, as carbohydrate chains influence immune responses and disease progression. Altered glycosylation patterns can disrupt cytokine release balance, contributing to chronic inflammatory conditions. Understanding these mechanisms opens new avenues for therapeutic interventions targeting glycan modifications, potentially improving outcomes in conditions like rheumatoid arthritis and inflammatory bowel disease.